Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
HeartFlow Beats Earnings Expectations But Stock Falls 8% on Weak Guidance
Investing.com – Heartflow, Inc. (NASDAQ:HTFL) announced its Q4 earnings exceeded analyst expectations, but the company’s 2026 revenue guidance disappointed investors, causing the stock to plummet 7.6% in after-hours trading on Wednesday.
The AI-based coronary artery disease diagnosis company reported a Q4 adjusted loss of $0.12 per share, better than the consensus estimate of a $0.15 loss. Revenue reached $49.1 million, up 40% year-over-year from $35.1 million. However, the company’s 2026 revenue guidance of $218 million to $222 million, with a midpoint of $220 million, seemed to fall short of market expectations.
Heartflow President and CEO John Farquhar said, “Our strong Q4 performance caps off a record-breaking year. The rapid adoption of the Heartflow platform, combined with our disciplined execution in commercial, innovation, and clinical initiatives, drove 40% revenue growth for the quarter and the full year, with gross margin reaching an all-time high.”
The company’s adjusted gross margin for the quarter expanded from 75.3% last year to 79.9%, driven by increased case volume and productivity improvements from AI efficiency initiatives. As of December 31, 2025, the number of installed U.S. customers increased to 1,465, with 489 U.S. Plaque installed customers. Aetna began underwriting Heartflow Plaque Analysis this quarter, bringing the number of insured Plaque cases in the U.S. to about 75%.
For fiscal 2026, the company expects revenue to grow approximately 24% to 26% year-over-year, with an adjusted gross margin of 80% to 81%. For fiscal 2025, total revenue was $176 million, a 40% increase year-over-year.
This article was translated with the assistance of artificial intelligence. For more information, please see our Terms of Use.